[Targeted therapy of pulmonary arterial hypertension (PAH)]

MeSH terms

• Adult
• Antihypertensive Agents / adverse effects
• Antihypertensive Agents / therapeutic use
• Combined Modality Therapy
• Cooperative Behavior*
• Drug Approval
• Drug Therapy, Combination
• Endothelin Receptor Antagonists / adverse effects
• Endothelin Receptor Antagonists / therapeutic use
• Evidence-Based Medicine
• Humans
• Hypertension, Pulmonary / diagnosis
• Hypertension, Pulmonary / drug therapy*
• Hypertension, Pulmonary / mortality
• Interdisciplinary Communication*
• Molecular Targeted Therapy / methods*
• Phosphodiesterase 5 Inhibitors / adverse effects
• Phosphodiesterase 5 Inhibitors / therapeutic use
• Pyrazoles / adverse effects
• Pyrazoles / therapeutic use
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use
• Randomized Controlled Trials as Topic
• Survival Rate
• Treatment Outcome